BioMarin CEO says ‘the system will have to determine’ the worth of its new $702,000 drug

Jim Cramer spoke with JJ Bienaimé for more on the company’s newest drug that treats a very rare disease. Source Author: CNBC Are you interested in building wealth with stocks and bonds? Be sure to check out our Automated Robo-Advisor Solutions. #CNBC #Finance #FinancialMarkets #Investing #Equities #RealEstate #Stocks #Bonds